Analyst Raises Venture Global VG Price Target by 2 Signaling Potential Upside AnheuserBusch InBev Shares Dip After Revenue Misses Market Expectations Rovida Investment Management Discloses 102 Million Stake in H World Group Amid Stock Rally Sebi Uncovers PumpandDump Scheme Using Social Media to Inflate 82 SME Stocks Yardeni Warns Fed May Need to Raise Rates in July to Pacify Bond Vigilantes Under Incoming Chair Warsh SpaceX IPO Could Lift Space Sector Sentiment With Rocket Lab Seen as Potential Beneficiary Flexible Solutions International FSI Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises Unexpectedly CREG Q1 2026 Earnings Reported Loss Per Share of 003 Stock Declines 125 Amid Missing Revenue Data Energous Corporation WATT Q1 2026 Earnings EPS Surprises to the Upside Amid Zero Revenue Quarter Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected LSF Q1 2026 Earnings Stunning EPS Beat Drives Positive Investor Sentiment AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower Chenghe Acquisition III Co CHEC Holds Steady at 1011 as SPAC Sector Watches for Catalyst Aptiv PLC APTV Surges 27 as Stock Approaches Key Resistance Level LMP Capital and Income Fund SCD Modestly Higher as Price Approaches Key Resistance Olin Corporation OLN Gains Momentum Stock Rises 281 Amid Sector Dynamics SR Bancorp SRBK Holds Steady Near Support Amid Low Volume Paul Tudor Jones Sees No Chance of Fed Rate Cuts Under Potential Warsh Leadership enVVeno Medical NVNO Q3 2025 Earnings NarrowerThanExpected Loss Signals Cost Discipline Progress Equity Lifestyle Properties ELS Declines Support Levels Under Scrutiny After 172 Drop PHG Q1 2026 Earnings EPS Surprise Lifts but Stock Weakness Raises Caution ET Q1 2026 Earnings EPS Misses Estimates as Midstream Operations Face Headwinds ICHR Q1 2026 Earnings EPS Surpasses Expectations Stock Rises Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline BHP Q1 2026 Earnings EPS Falls Short of Estimates Amid Commodity Headwinds ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress CI Q1 2026 Earnings EPS Misses Estimates by 065 Stock Edges Lower